Lausanne, Vaud, Switzerland · Hybrid
We are looking for a Finance Analyst to join our growing Finance team. This role offers broad exposure across FP&A, business partnering, finance operations and controlling activities. The primary focus of this role is sa…
Skills: FP&A, Business Partnering, Financial Reporting, Budgeting, Forecasting
Lausanne, Vaud, Switzerland · On-site
The Quality Operations Engineer plays a critical role in ensuring that products manufactured by external suppliers and CMOs meet applicable regulatory, quality, and business requirements. This individual serves as a key …
Skills: Quality Assurance, ISO 13485, FDA QSR, GxP, Batch Record Review
Lausanne, Vaud, Switzerland · On-site
Android App Development & Cloud Connectivity Internship ONWARD Medical develops breakthrough therapies that restore movement and independence in people living with spinal cord injuries. Our Software & Digital Team plays …
Skills: Android Development, Kotlin, .NET, C#, Java
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The role focuses on sales finance, managing the commercial cycle from invoicing to COGS and inventory management. It also involves supporting FP&A activities including budgeting, forecasting, and variance analysis to drive financial performance.
Candidates must have a Bachelor's degree in Finance, Accounting, or Economics and over 3 years of experience in a similar finance role. Proficiency in Excel and ERP systems, along with strong analytical and communication skills, is required.
Empowering Movement
ONWARD Medical is a neurotechnology company pioneering therapies to restore movement, function, and independence in people living with spinal cord injuries and other movement disabilities. Our purpose-designed technology platforms are designed to deliver targeted, programmed spinal cord stimulation: · The external ARC-EX® System is the first FDA-cleared device for both clinic and at-home use indicated to improve hand strength and sensation after spinal cord injury. ARC-EX is supported by 10+ peer-reviewed publications. It was named one of TIME magazine’s Best Inventions and recognized among Fast Company’s World Changing Ideas for its potential to transform lives. · The investigational ARC-IM® System is an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. It is designed to address several unmet needs, including blood pressure instability after spinal cord injury. Empower BP is the first global pivotal study to evaluate the safety and effectiveness of the investigational ARC-IM in addressing blood pressure instability in people living with SCI. · The investigational ARC-BCI® System is the world’s most advanced purpose-built platform pairing a brain-computer interface with an implantable spinal cord stimulation system and artificial intelligence to restore thought-driven movement after paralysis. We are dedicated to addressing the most pressing needs of people living with SCI and other movement disabilities. We collaborate closely with rehabilitation clinics, caregivers, and people living with SCI to accelerate innovation and access to care. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD), and its US ADRs can be traded on OTCQX (ticker: ONWRY).
Offices: Eindhoven, 5611 ZX, NL · Boston, US · Lausanne, CH
Empowering Movement
ONWARD Medical is a neurotechnology company pioneering therapies to restore movement, function, and independence in people living with spinal cord injuries and other movement disabilities. Our purpose-designed technology platforms are designed to deliver targeted, programmed spinal cord stimulation: · The external ARC-EX® System is the first FDA-cleared device for both clinic and at-home use indicated to improve hand strength and sensation after spinal cord injury. ARC-EX is supported by 10+ peer-reviewed publications. It was named one of TIME magazine’s Best Inventions and recognized among Fast Company’s World Changing Ideas for its potential to transform lives. · The investigational ARC-IM® System is an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. It is designed to address several unmet needs, including blood pressure instability after spinal cord injury. Empower BP is the first global pivotal study to evaluate the safety and effectiveness of the investigational ARC-IM in addressing blood pressure instability in people living with SCI. · The investigational ARC-BCI® System is the world’s most advanced purpose-built platform pairing a brain-computer interface with an implantable spinal cord stimulation system and artificial intelligence to restore thought-driven movement after paralysis. We are dedicated to addressing the most pressing needs of people living with SCI and other movement disabilities. We collaborate closely with rehabilitation clinics, caregivers, and people living with SCI to accelerate innovation and access to care. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD), and its US ADRs can be traded on OTCQX (ticker: ONWRY).
Offices: Eindhoven, 5611 ZX, NL · Boston, US · Lausanne, CH
